Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Prevention of varicella : updated recommendations of the Advisory Committee on Immunization Practices (ACIP)
Filetype[PDF-156.68 KB]


Details:
  • Supporting Files:
    No Additional Files
This document has replaced (most recent first):
  1. Prevention of varicella; recommendations of the Advisory Committee on Immunization Practices
    Personal Author:
    Holmes, Sandra J.; Reef, Susan E.; Hadler, Stephen C.; Williams, Walter W.; Wharton, Melinda;
    Corporate Authors:
    United States, Advisory Committee on Immunization Practices.. National Immunization Program (Centers for Disease Control and Prevention), Epidemiology and Surveillance Division..
    Published Date:
    July 12, 1996
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 45, no. RR-11
    Description:
    "These recommendations represent the first statement by the Advisory Committee on Immunization Practices (ACIP) on the use of live, attenuated varicella virus vaccine--VARIVAX--manufactured by Merck and Company, Inc. and licensed in March 1995 for us...
    Status:
    superseded
    File Type:
    Filetype[PDF - 307.65 KB]
You May Also Like:
  1. Guidelines for vaccinating pregnant women; abstracted from recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Corporate Authors:
    United States, Advisory Committee on Immunization Practices.. Centers for Disease Control and Prevention (U.S.).
    Published Date:
    March 2013
    Description:
    The table on the following page may be used to find the general rule for vaccinating a pregnant woman with a particular vaccine. The third column of the table refers the reader to the page in this document where more specific information from the app...
    File Type:
    Filetype[PDF - 1.46 MB]
  2. Use of combination measles, mumps, rubella, and varicella vaccine : recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Personal Author:
    Marin, Mona; Broder, Karen R.; Temte, Jonathan L.; Snider, Dixie E.; Seward, Jane F.;
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.. United States. Advisory Committee on Immunization Practices..
    Published Date:
    May 7, 2010
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2010; 59(RR-3):1-12.
    Description:
    This report presents new recommendations adopted in June 2009 by CDC's Advisory Committee on Immunization Practices (ACIP) regarding use of the combination measles, mumps, rubella, and varicella vaccine (MMRV, ProQuad, Merck & Co., Inc.). MMRV vaccin...
    Status:
    current
    File Type:
    Filetype[PDF - 225.41 KB]
  3. Update on Recommendations for Use of Herpes Zoster Vaccine
    Personal Author:
    Hales, Craig M.; Harpaz, Rafael; Ortega-Sanchez, Ismael; Bialek, Stephanie R.;
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.
    Published Date:
    Aug 22 2014
    Source:
    MMWR Morb Mortal Wkly Rep. 2014; 63(33):729-731.
    Description:
    Herpes zoster vaccine (Zostavax [Merck & Co., Inc.]) was licensed in 2006 and recommended by the Advisory Committee on Immunization Practices (ACIP) in 2008 for prevention of herpes zoster (shingles) and its complications among adults aged ≥60 year...
    File Type:
    Filetype[PDF - 109.32 KB]
  4. Update: Recommendations from the Advisory Committee on Immunization Practices (ACIP) regarding administration of combination MMRV vaccine. MMWR 2008. 57 (10): 258-260.
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.. Centers for Disease Control and Prevention (U.S.).
    Published Date:
    March 14, 2008
    Source:
    MMWR. Morbidity and mortality weekly report. 2008; 57(10):258-60.
    Description:
    On February 27, 2008, new information was presented to the Advisory Committee on Immunization Practices (ACIP) regarding the risk for febrile seizures among children aged 12--23 months after administration of the combination measles, mumps, rubella, ...
    Status:
    superseded
    File Type:
    Filetype[HTML]
  5. Update on recommendations for use of herpes zoster vaccine
    Personal Author:
    Hales, Craig M.; Harpaz, Rafael; Ortega-Sanchez, Ismael; Bialek, Stephanie R.;
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases..
    Published Date:
    August 22, 2014
    Series:
    MMWR. Morbidity and mortality weekly report, Vol. 63, no. 33, p. 729-31
    Description:
    Herpes zoster vaccine (Zostavax [Merck & Co., Inc.]) was licensed in 2006 and recommended by the Advisory Committee on Immunization Practices (ACIP) in 2008 for prevention of herpes zoster (shingles) and its complications among adults aged ≥60 year...
    Status:
    current
    File Type:
    Filetype[PDF - 195.85 KB]